In diverse cancers, levels of p-ERK1/2 were correlated with upregulation of vimentin, snail, N-cadherin, and MMP-9, with a decrease in E-cadherin expression (Hong et al., 2016; Liu B. et al., 2018). This evidence concerns the gene CDH2 and cancer.